iBIO, Inc. (NYSE MKT: IBIO) shares traded as high as $1.70 in early trading but then sold off after investors learned that much of the firm’s recent run was fueled by paid stock promoters. The firm announced this morning that they had joined GE Healthcare, the healthcare business of GE (NYSE:GE), in a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines, but no financial information or guidance was issued to help guide the market as to the meaning of the news development. Shares of the company have traded as low as $ 0.65 and as high as $3.45 during the past 52 weeks